Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
Public ClinicalTrials.gov record NCT02452190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52-Week Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Reslizumab 110 mg Fixed, Subcutaneous Dosing in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the effect of reslizumab (110 mg) administered subcutaneously every 4 weeks on clinical asthma exacerbations in adults and adolescents with asthma and elevated blood eosinophils who are inadequately controlled on standard-of-care asthma therapy.
Study identification
- NCT ID
- NCT02452190
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 468 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 28, 2015 (Actual)
- Primary completion
- Dec 4, 2017 (Actual)
- Completion
- Jan 31, 2018 (Actual)
- Last update posted
- Nov 9, 2021
2015 – 2018
United States locations
- U.S. sites
- 69
- U.S. states
- 29
- U.S. cities
- 65
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13212 | Birmingham | Alabama | 35209 | — |
| Teva Investigational Site 13241 | Flagstaff | Arizona | 86001 | — |
| Teva Investigational Site 13194 | Glendale | Arkansas | 85306 | — |
| Teva Investigational Site 13215 | Bakersfield | California | 93301 | — |
| Teva Investigational Site 13181 | Canoga Park | California | 91303 | — |
| Teva Investigational Site 13254 | Fresno | California | 93720 | — |
| Teva Investigational Site 13216 | Huntington Beach | California | 92647 | — |
| Teva Investigational Site 13247 | Long Beach | California | 90813 | — |
| Teva Investigational Site 13205 | Napa | California | 94558 | — |
| Teva Investigational Site 13764 | San Jose | California | 95117 | — |
| Teva Investigational Site 13252 | Stockton | California | 95207 | — |
| Teva Investigational Site 13251 | Walnut Creek | California | 94598 | — |
| Teva Investigational Site 13229 | Denver | Colorado | 80206 | — |
| Teva Investigational Site 13766 | Waterbury | Connecticut | 06708 | — |
| Teva Investigational Site 13196 | Aventura | Florida | 33180 | — |
| Teva Investigational Site 13256 | Fort Lauderdale | Florida | 33308 | — |
| Teva Investigational Site 13203 | Kissimmee | Florida | 34741 | — |
| Teva Investigational Site 13197 | Miami | Florida | 33125 | — |
| Teva Investigational Site 13220 | Miami | Florida | 33155 | — |
| Teva Investigational Site 13243 | Miami | Florida | 33176 | — |
| Teva Investigational Site 13233 | New Port Richey | Florida | 34653 | — |
| Teva Investigational Site 13201 | Orlando | Florida | 32811 | — |
| Teva Investigational Site 13250 | Orlando | Florida | 32819 | — |
| Teva Investigational Site 13246 | Pembroke Pines | Florida | 33029 | — |
| Teva Investigational Site 13208 | Tallahassee | Florida | 32308 | — |
| Teva Investigational Site 13255 | Tampa | Florida | 33607 | — |
| Teva Investigational Site 13765 | Albany | Georgia | 31707 | — |
| Teva Investigational Site 13249 | Buford | Georgia | 30518 | — |
| Teva Investigational Site 13763 | Lawrenceville | Georgia | 30045 | — |
| Teva Investigational Site 13230 | Chicago | Illinois | 60612 | — |
| Teva Investigational Site 13211 | Normal | Illinois | 61761 | — |
| Teva Investigational Site 13235 | Shiloh | Illinois | 62269 | — |
| Teva Investigational Site 13202 | Michigan City | Indiana | 46360 | — |
| Teva Investigational Site 13225 | Lenexa | Kansas | 66215 | — |
| Teva Investigational Site 13222 | Owensboro | Kentucky | 42301 | — |
| Teva Investigational Site 13191 | Lafayette | Louisiana | 70503 | — |
| Teva Investigational Site 13200 | North Dartmouth | Massachusetts | 02747 | — |
| Teva Investigational Site 13226 | Biloxi | Mississippi | 39531 | — |
| Teva Investigational Site 13204 | St Louis | Missouri | 63143 | — |
| Teva Investigational Site 13258 | Boys Town | Nebraska | 68010 | — |
| Teva Investigational Site 13769 | Belleville | New Jersey | 07109 | — |
| Teva Investigational Site 13210 | Ocean City | New Jersey | 07712 | — |
| Teva Investigational Site 13188 | New Hyde Park | New York | 11040 | — |
| Teva Investigational Site 13232 | New York | New York | 10016 | — |
| Teva Investigational Site 13767 | New York | New York | 11570 | — |
| Teva Investigational Site 13186 | Cincinnati | Ohio | 45267 | — |
| Teva Investigational Site 13253 | Cleveland | Ohio | 44106 | — |
| Teva Investigational Site 13240 | Toledo | Ohio | 43606 | — |
| Teva Investigational Site 13259 | Edmond | Oklahoma | 73034 | — |
| Teva Investigational Site 13238 | Oklahoma City | Oklahoma | 73112 | — |
| Teva Investigational Site 13195 | Medford | Oregon | 97504 | — |
| Teva Investigational Site 13242 | Bethlehem | Pennsylvania | 18020 | — |
| Teva Investigational Site 13218 | Jenkintown | Pennsylvania | 19046 | — |
| Teva Investigational Site 13189 | Philadelphia | Pennsylvania | 19107 | — |
| Teva Investigational Site 13190 | Pittsburgh | Pennsylvania | 15241 | — |
| Teva Investigational Site 13209 | East Providence | Rhode Island | ?02914 | — |
| Teva Investigational Site 13217 | Lincoln | Rhode Island | 02865 | — |
| Teva Investigational Site 13223 | Knoxville | Tennessee | 37919 | — |
| Teva Investigational Site 13185 | Arlington | Texas | 76018 | — |
| Teva Investigational Site 13199 | Corsicana | Texas | 75110 | — |
| Teva Investigational Site 13260 | Dallas | Texas | 75225 | — |
| Teva Investigational Site 13224 | San Antonio | Texas | 78229 | — |
| Teva Investigational Site 13184 | Waco | Texas | 76712 | — |
| Teva Investigational Site 13187 | Provo | Utah | 84604 | — |
| Teva Investigational Site 13207 | Abingdon | Virginia | 24210 | — |
| Teva Investigational Site 13183 | Fairfax | Virginia | 22030 | — |
| Teva Investigational Site 13257 | Falls Church | Virginia | 22044 | — |
| Teva Investigational Site 13239 | Richmond | Virginia | 23233 | — |
| Teva Investigational Site 13227 | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 157 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02452190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2021 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02452190 live on ClinicalTrials.gov.